Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...
Researchers at the Josep Carreras Leukaemia Research Institute propose a new view of cancer based on spatial hallmark ecosystems and its evolution during cancer progression. This conceptual framework ...
Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and ...
Early-stage cancer immunotherapy represents a promising yet underexplored frontier in cancer research. While immunotherapeutic strategies have achieved ...
Treatment with programmed cell death 1/programmed cell death ligand 1 inhibitors for Kaposi sarcoma: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
The field of cancer immunology has seen significant advancements in recent years, particularly with the emergence of immunotherapy as a key pillar in the ...
A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...
Microsoft CEO, Satya Nadella, has unveiled a new artificial intelligence, GigaTIME, capable of simulating intricate cancer ...
Health and Me on MSN
Microsoft's new AI model GigaTIME to expand access to cancer care, says CEO Satya Nadella
GigaTIME can transform routine pathology slides into detailed spatial proteomics data -- a high-resolution map of proteins -- ...
HKUMed reveals that Resmetirom, a drug for treating metabolic dysfunction-associated fatty liver disease (MAFLD), has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results